SANGAMO THERAPEUTICS INC (SGMO)       3.66  +0.12 (+3.39%)

3.66  +0.12 (+3.39%)

US8006771062 - Common Stock - After market: 3.66 0 (0%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -0.34 -0.36 0.026.22% Q2 2022 -0.29 -0.36 0.0719.40% Q1 2022 -0.30 -0.32 0.025.43% Q4 2021 -0.26 -0.35 0.0926.21% Q3 2021 -0.33 -0.34 0.014.00% Q2 2021 -0.33 -0.32 -0.01-3.45% Q1 2021 -0.32 -0.30 -0.02-6.84% Q4 2020 -0.29 -0.22 -0.07-33.65%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -1.35 -1.24 -8.58%Q4 2022 -0.37 -0.26 -42.30%FY 2023 -1.36 -1.35 -0.83%Q1 2023 -0.37 -0.30 -23.86%Q2 2023 -0.38 -0.29 -29.63%Q3 2023 -0.39 -0.34 -15.71%Q4 2023 -0.41 -0.37 -9.49%FY 2024 -1.30 -1.36 4.25%Q1 2024 -0.47 -0.37 -26.27%Q2 2024 -0.50 -0.38 -32.95%Q3 2024 -0.56 -0.39 -42.59%Q4 2024 -0.59 -0.41 -46.04%FY 2025 -1.30 -1.30 0.28%Q1 2025 -0.54 -0.47 -15.22%Q2 2025 -0.57 -0.50 -14.29%Q3 2025 -0.67 -0.56 -20.00%FY 2026 -1.32 -1.30 -1.71%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 26.46M 27.321M -861K-3.15% Q2 2022 29.378M 25.123M 4.255M16.94% Q1 2022 28.231M 27.831M 400K1.44% Q4 2021 27.986M 27.36M 626K2.29% Q3 2021 28.563M 25.693M 2.87M11.17% Q2 2021 27.872M 27.014M 858K3.18% Q1 2021 26.28M 25.146M 1.134M4.51% Q4 2020 25.8M 32.795M -6.995M-21.33%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 113.26M 110.701M 2.31%Q4 2022 27.394M 27.986M -2.12%FY 2023 126.57M 113.26M 11.75%Q1 2023 26.911M 28.231M -4.68%Q2 2023 27.931M 29.378M -4.93%Q3 2023 26.367M 26.46M -0.35%Q4 2023 25.347M 27.394M -7.47%FY 2024 145.83M 126.57M 15.22%Q1 2024 21.522M 26.911M -20.03%Q2 2024 21.522M 27.931M -22.95%Q3 2024 15.096M 26.367M -42.75%Q4 2024 15.096M 25.347M -40.44%FY 2025 154.55M 145.83M 5.98%Q1 2025 28.152M 21.522M 30.81%Q2 2025 28.152M 21.522M 30.81%Q3 2025 16.524M 15.096M 9.46%FY 2026 158.3M 154.55M 2.43%